220 related articles for article (PubMed ID: 28262225)
21. Psychotropic Drugs and Outcome in Patients Receiving Anticoagulant Therapy for Venous Thromboembolism.
Marchena PJ; Tzoran I; Brenner B; Martín M; Malý R; Bura-Riviere A; Valle R; Hernández-Blasco L; López-Sáez JB; Monreal M;
Thromb Haemost; 2020 Apr; 120(4):620-626. PubMed ID: 32289861
[TBL] [Abstract][Full Text] [Related]
22. Gender differences in cancer patients with acute venous thromboembolism.
Martín-Martos F; Trujillo-Santos J; Barrón M; Vela J; Javier Marchena P; Braester A; Hij A; Hernández-Blasco L; Verhamme P; Manuel M;
Thromb Res; 2015 Feb; 135 Suppl 1():S12-5. PubMed ID: 25903526
[TBL] [Abstract][Full Text] [Related]
23. Venous Thromboembolism in Patients With Autoimmune Disorders: Findings From the RIETE Registry.
Sada PR; López-Núñez JJ; Samperiz A; Soto MJ; Pedrajas JM; Porras JA; Peris ML; Olivé A; Debourdeau P; Pace F; Monreal M;
Angiology; 2020 Feb; 71(2):131-138. PubMed ID: 31578072
[TBL] [Abstract][Full Text] [Related]
24. Sex differences in patients receiving anticoagulant therapy for venous thromboembolism.
Blanco-Molina A; Enea I; Gadelha T; Tufano A; Bura-Riviere A; Di Micco P; Bounameaux H; González J; Villalta J; Monreal M;
Medicine (Baltimore); 2014 Oct; 93(17):309-317. PubMed ID: 25398066
[TBL] [Abstract][Full Text] [Related]
25. Management and outcome of major bleeding in patients receiving vitamin K antagonists for venous thromboembolism.
Moustafa F; Stehouwer A; Kamphuisen P; Sahuquillo JC; Sampériz Á; Alfonso M; Pace F; Suriñach JM; Blanco-Molina Á; Mismetti P; Monreal M;
Thromb Res; 2018 Nov; 171():74-80. PubMed ID: 30265883
[TBL] [Abstract][Full Text] [Related]
26. Clinical outcome in patients with venous thromboembolism receiving concomitant anticoagulant and antiplatelet therapy.
Tzoran I; Brenner B; Sakharov G; Trujillo-Santos J; Lorenzo A; Madridano O; López-Sáez JB; Monreal M;
Eur J Intern Med; 2014 Nov; 25(9):821-5. PubMed ID: 25287697
[TBL] [Abstract][Full Text] [Related]
27. Recurrent venous thromboembolism and abnormal uterine bleeding with anticoagulant and hormone therapy use.
Martinelli I; Lensing AW; Middeldorp S; Levi M; Beyer-Westendorf J; van Bellen B; Bounameaux H; Brighton TA; Cohen AT; Trajanovic M; Gebel M; Lam P; Wells PS; Prins MH
Blood; 2016 Mar; 127(11):1417-25. PubMed ID: 26696010
[TBL] [Abstract][Full Text] [Related]
28. Duration of anticoagulation after venous thromboembolism in real world clinical practice.
Ageno W; Samperiz A; Caballero R; Dentali F; Di Micco P; Prandoni P; Becattini C; Uresandi F; Verhamme P; Monreal M;
Thromb Res; 2015 Apr; 135(4):666-72. PubMed ID: 25708926
[TBL] [Abstract][Full Text] [Related]
29. Lessons from VTE registries: the RIETE experience.
Monreal M; Trujillo-Santos J
Best Pract Res Clin Haematol; 2009 Mar; 22(1):25-33. PubMed ID: 19285270
[TBL] [Abstract][Full Text] [Related]
30. Abnormal uterine bleeding in women receiving direct oral anticoagulants for the treatment of venous thromboembolism.
Godin R; Marcoux V; Tagalakis V
Vascul Pharmacol; 2017 Aug; 93-95():1-5. PubMed ID: 28479313
[TBL] [Abstract][Full Text] [Related]
31. Outcomes during anticoagulation in patients with symptomatic vs. incidental splanchnic vein thrombosis.
Tufano A; Ageno W; Di Micco P; Niglio A; Rosa V; Ballaz A; Braester A; Rubio CM; Isern V; Imbalzano E; Monreal M;
Thromb Res; 2018 Apr; 164():69-74. PubMed ID: 29499439
[TBL] [Abstract][Full Text] [Related]
32. Liver status and outcomes in patients without previous known liver disease receiving anticoagulant therapy for venous thromboembolism.
Martínez-Urbistondo D; de la Garza RG; Villares-Fernández P; Font C; Schellong S; López-Núñez JJ; Gil-Díaz A; Del Carmen Díaz-Pedroche M; Hirmerova J; Monreal M;
Intern Emerg Med; 2022 Apr; 17(3):725-734. PubMed ID: 34626318
[TBL] [Abstract][Full Text] [Related]
33. Risk Factors for Major Bleeding during Prolonged Anticoagulation Therapy in Patients with Venous Thromboembolism: From the COMMAND VTE Registry.
Kim K; Yamashita Y; Morimoto T; Kitai T; Yamane T; Ehara N; Kinoshita M; Kaji S; Amano H; Takase T; Hiramori S; Oi M; Akao M; Kobayashi Y; Toyofuku M; Izumi T; Tada T; Chen PM; Murata K; Tsuyuki Y; Saga S; Sasa T; Sakamoto J; Kinoshita M; Togi K; Mabuchi H; Takabayashi K; Shiomi H; Kato T; Makiyama T; Ono K; Furukawa Y; Kimura T;
Thromb Haemost; 2019 Sep; 119(9):1498-1507. PubMed ID: 31230344
[TBL] [Abstract][Full Text] [Related]
34. Tinzaparin and VKA use in patients with cancer associated venous thromboembolism: a retrospective cohort study.
Noel-Savina E; Sanchez O; Descourt R; André M; Leroyer C; Meyer G; Couturaud F
Thromb Res; 2015 Jan; 135(1):78-83. PubMed ID: 25466839
[TBL] [Abstract][Full Text] [Related]
35. Predicting recurrences or major bleeding in cancer patients with venous thromboembolism. Findings from the RIETE Registry.
Trujillo-Santos J; Nieto JA; Tiberio G; Piccioli A; Di Micco P; Prandoni P; Monreal M;
Thromb Haemost; 2008 Sep; 100(3):435-9. PubMed ID: 18766259
[TBL] [Abstract][Full Text] [Related]
36. Abnormal uterine bleeding in VTE patients treated with rivaroxaban compared to vitamin K antagonists.
De Crem N; Peerlinck K; Vanassche T; Vanheule K; Debaveye B; Middeldorp S; Verhamme P; Peetermans M
Thromb Res; 2015 Oct; 136(4):749-53. PubMed ID: 26272306
[TBL] [Abstract][Full Text] [Related]
37. Venous thromboembolism characteristics, treatment and outcomes in young adults: findings from the Registro Informatizado de Enfermedad TromboEmbólica registry.
Cohen O; Barg AA; Nowak-Göttl U; Amado-Fernández C; Mazzolai L; Tiberio G; Schellong S; Skride A; Morales MDV; Monreal M; Kenet G;
J Thromb Haemost; 2023 Oct; 21(10):2811-2823. PubMed ID: 37406932
[TBL] [Abstract][Full Text] [Related]
38. Venous Thromboembolism in Patients with Liver Cirrhosis: Findings from the RIETE (Registro Informatizado de la Enfermedad TromboEmbolica) Registry.
Bikdeli B; Jiménez D; Garcia-Tsao G; Barba R; Font C; Díaz-Pedroche MDC; Mazzolai L; Little DHW; Tufano A; Tafur AJ; Siegal D; Lip GYH; Monreal M;
Semin Thromb Hemost; 2019 Nov; 45(8):793-801. PubMed ID: 31614388
[TBL] [Abstract][Full Text] [Related]
39. Clinical characteristics and outcomes of venous thromboembolic events after hallux valgus surgery: insights from the RIETE registry.
Bikdeli B; Visvanathan R; Weinberg I; Rivas A; Nieto JA; Sampériz Á; Loring M; Vázquez FJ; Yoo HHB; Bikdeli B; Monreal M
J Thromb Thrombolysis; 2020 May; 49(4):651-658. PubMed ID: 31898272
[TBL] [Abstract][Full Text] [Related]
40. Predictors of recurrent venous thromboembolism and bleeding on anticoagulation.
Menapace LA; McCrae KR; Khorana AA
Thromb Res; 2016 Apr; 140 Suppl 1():S93-8. PubMed ID: 27067987
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
